Publication | Closed Access
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial
197
Citations
24
References
2022
Year
Concurrent use of patiromer and high-dose MRAs reduces the risk of recurrent hyperkalemia (ClinicalTrials.gov: NCT03888066).
| Year | Citations | |
|---|---|---|
Page 1
Page 1